Home/Etcembly/Jacob Hurst
JH

Jacob Hurst

CTO & Co-founder

Etcembly

Therapeutic Areas

Etcembly Pipeline

DrugIndicationPhase
Zelluna TCR-NK Candidate (Platform-Optimized)Not Specified (Likely Oncology)Pre-clinical